Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum
Main Author: | |
---|---|
Publication Date: | 2019 |
Other Authors: | , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da UNESP |
Download full: | http://dx.doi.org/10.1016/j.theriogenology.2018.09.024 http://hdl.handle.net/11449/185323 |
Summary: | The aim of this study was to determine the expression of fibroblast growth factor 22 (FGF22) in the bovine corpus luteum (CL) and to investigate the effects of in vivo total or partial cloprostenol-induced luteolysis on the mRNA abundance of FGF22 and its receptor, FGFR1B. Corpora lutea at different stages of development were then dissected from abattoir ovaries (n = 10/stage); a portion of the tissue samples was fixed in paraformaldehyde and the remaining samples were homogenized and subjected to total RNA extraction. To assess mRNA abundance of target genes during induced luteolysis, nineteen cows were synchronized and then randomly assigned to a Latin square design as follows: Control; 2 administrations of prostaglandin F-2 alpha (PGF(2 alpha), total luteolysis; 2 x 250 mu g of cloprostenol sodium) and 1/6PGF(2 alpha) (partial luteolysis; 83.33 mu g of cloprostenol sodium). FGF22 and FGFR1B expression levels were measured by RT-qPCR, and FGF22 protein expression was detected by immunohistochemistry. In summary, FGF22 mRNA was detected at all stages of CL development, and FGF22 protein was also detected in luteal tissue. FGF22 mRNA expression was lower at stage IV than at stage III (P < 0.05), and the same pattern was observed in luteal immunoreactivity. Furthermore, cloprostenol-induced luteolysis, both total and partial, increased FGFR1B mRNA abundance in luteal tissue (P < 0.05), but did not affect FGF22 mRNA abundance. In conclusion, these data suggest a potential role for the FGF22-FGFR1B system during development and regression of bovine CL. (C) 2018 Elsevier Inc. All rights reserved. |
id |
UNSP_c2935b578bd9f74acbda9a76b6941ca8 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/185323 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteumCorpora luteaLuteal developmentFGF7 subfamilyCattleThe aim of this study was to determine the expression of fibroblast growth factor 22 (FGF22) in the bovine corpus luteum (CL) and to investigate the effects of in vivo total or partial cloprostenol-induced luteolysis on the mRNA abundance of FGF22 and its receptor, FGFR1B. Corpora lutea at different stages of development were then dissected from abattoir ovaries (n = 10/stage); a portion of the tissue samples was fixed in paraformaldehyde and the remaining samples were homogenized and subjected to total RNA extraction. To assess mRNA abundance of target genes during induced luteolysis, nineteen cows were synchronized and then randomly assigned to a Latin square design as follows: Control; 2 administrations of prostaglandin F-2 alpha (PGF(2 alpha), total luteolysis; 2 x 250 mu g of cloprostenol sodium) and 1/6PGF(2 alpha) (partial luteolysis; 83.33 mu g of cloprostenol sodium). FGF22 and FGFR1B expression levels were measured by RT-qPCR, and FGF22 protein expression was detected by immunohistochemistry. In summary, FGF22 mRNA was detected at all stages of CL development, and FGF22 protein was also detected in luteal tissue. FGF22 mRNA expression was lower at stage IV than at stage III (P < 0.05), and the same pattern was observed in luteal immunoreactivity. Furthermore, cloprostenol-induced luteolysis, both total and partial, increased FGFR1B mRNA abundance in luteal tissue (P < 0.05), but did not affect FGF22 mRNA abundance. In conclusion, these data suggest a potential role for the FGF22-FGFR1B system during development and regression of bovine CL. (C) 2018 Elsevier Inc. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Natural Sciences and Engineering Research Council of Canada (NSERC)Univ Oeste Paulista, Campus 2, BR-19067175 Presidente Prudente, SP, BrazilUniv Estadual Paulista, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Botucatu, SP, BrazilUniv Estadual Paulista, Inst Biociencias, Dept Farmacol, Botucatu, SP, BrazilUniv Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ, CanadaUniv Estadual Paulista, Inst Biociencias, Dept Fisiol, Botucatu, SP, BrazilUniv Estadual Paulista, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Botucatu, SP, BrazilUniv Estadual Paulista, Inst Biociencias, Dept Farmacol, Botucatu, SP, BrazilUniv Estadual Paulista, Inst Biociencias, Dept Fisiol, Botucatu, SP, BrazilElsevier B.V.Univ Oeste PaulistaUniversidade Estadual Paulista (Unesp)Univ MontrealCastilho, A. C. S.Dalanezi, F. M. [UNESP]Franchi, F. F. [UNESP]Price, C. A.Ferreira, J. C. P. [UNESP]Trevisol, E. [UNESP]Buratini, J. [UNESP]2019-10-04T12:34:27Z2019-10-04T12:34:27Z2019-02-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1-5http://dx.doi.org/10.1016/j.theriogenology.2018.09.024Theriogenology. New York: Elsevier Science Inc, v. 125, p. 1-5, 2019.0093-691Xhttp://hdl.handle.net/11449/18532310.1016/j.theriogenology.2018.09.024WOS:000455972500001Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengTheriogenologyinfo:eu-repo/semantics/openAccess2024-10-09T19:28:47Zoai:repositorio.unesp.br:11449/185323Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-10-09T19:28:47Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
title |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
spellingShingle |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum Castilho, A. C. S. Corpora lutea Luteal development FGF7 subfamily Cattle |
title_short |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
title_full |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
title_fullStr |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
title_full_unstemmed |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
title_sort |
Expression of fibroblast growth factor 22 (FGF22) and its receptor, FGFR1B, during development and regression of bovine corpus luteum |
author |
Castilho, A. C. S. |
author_facet |
Castilho, A. C. S. Dalanezi, F. M. [UNESP] Franchi, F. F. [UNESP] Price, C. A. Ferreira, J. C. P. [UNESP] Trevisol, E. [UNESP] Buratini, J. [UNESP] |
author_role |
author |
author2 |
Dalanezi, F. M. [UNESP] Franchi, F. F. [UNESP] Price, C. A. Ferreira, J. C. P. [UNESP] Trevisol, E. [UNESP] Buratini, J. [UNESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Univ Oeste Paulista Universidade Estadual Paulista (Unesp) Univ Montreal |
dc.contributor.author.fl_str_mv |
Castilho, A. C. S. Dalanezi, F. M. [UNESP] Franchi, F. F. [UNESP] Price, C. A. Ferreira, J. C. P. [UNESP] Trevisol, E. [UNESP] Buratini, J. [UNESP] |
dc.subject.por.fl_str_mv |
Corpora lutea Luteal development FGF7 subfamily Cattle |
topic |
Corpora lutea Luteal development FGF7 subfamily Cattle |
description |
The aim of this study was to determine the expression of fibroblast growth factor 22 (FGF22) in the bovine corpus luteum (CL) and to investigate the effects of in vivo total or partial cloprostenol-induced luteolysis on the mRNA abundance of FGF22 and its receptor, FGFR1B. Corpora lutea at different stages of development were then dissected from abattoir ovaries (n = 10/stage); a portion of the tissue samples was fixed in paraformaldehyde and the remaining samples were homogenized and subjected to total RNA extraction. To assess mRNA abundance of target genes during induced luteolysis, nineteen cows were synchronized and then randomly assigned to a Latin square design as follows: Control; 2 administrations of prostaglandin F-2 alpha (PGF(2 alpha), total luteolysis; 2 x 250 mu g of cloprostenol sodium) and 1/6PGF(2 alpha) (partial luteolysis; 83.33 mu g of cloprostenol sodium). FGF22 and FGFR1B expression levels were measured by RT-qPCR, and FGF22 protein expression was detected by immunohistochemistry. In summary, FGF22 mRNA was detected at all stages of CL development, and FGF22 protein was also detected in luteal tissue. FGF22 mRNA expression was lower at stage IV than at stage III (P < 0.05), and the same pattern was observed in luteal immunoreactivity. Furthermore, cloprostenol-induced luteolysis, both total and partial, increased FGFR1B mRNA abundance in luteal tissue (P < 0.05), but did not affect FGF22 mRNA abundance. In conclusion, these data suggest a potential role for the FGF22-FGFR1B system during development and regression of bovine CL. (C) 2018 Elsevier Inc. All rights reserved. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-10-04T12:34:27Z 2019-10-04T12:34:27Z 2019-02-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.theriogenology.2018.09.024 Theriogenology. New York: Elsevier Science Inc, v. 125, p. 1-5, 2019. 0093-691X http://hdl.handle.net/11449/185323 10.1016/j.theriogenology.2018.09.024 WOS:000455972500001 |
url |
http://dx.doi.org/10.1016/j.theriogenology.2018.09.024 http://hdl.handle.net/11449/185323 |
identifier_str_mv |
Theriogenology. New York: Elsevier Science Inc, v. 125, p. 1-5, 2019. 0093-691X 10.1016/j.theriogenology.2018.09.024 WOS:000455972500001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Theriogenology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1-5 |
dc.publisher.none.fl_str_mv |
Elsevier B.V. |
publisher.none.fl_str_mv |
Elsevier B.V. |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1834483396009525248 |